Papers: 10.1111/jcmm.16513

https://doi.org/10.1111/jcmm.16513

Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy

Cited by: 2
Author(s): Sabina Iluta, Sergiu Pașca, Grigore Gafencu, Ancuța Jurj, Andreea Terec, Patric Teodorescu, Cristina Selicean, Ciprian Jitaru, Alexandra Preda, Diana Cenariu, Cătălin Constantinescu, Maria Minodora Iordache, Bogdan Tigu, Raluca Munteanu, Richard Feder, Delia Dima, Dumitru Zdrenghea, Diana Gulei, Tudor-Eliade Ciuleanu, Ciprian Tomuleasa
Published: about 5 years ago

Software Mentions 1